NFKB1 and glioblastoma: In an attempt to decipher molecular drivers of MES reprogramming in GCSs, Bhat et al. identified a genetic signature associated with MES transition, radiation resistance, and poor GBM outcomes mediated through NF-κB signaling pathway activation [80].